Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan

Yuichi Tamura,Hiraku Kumamaru,Takumi Inami,Hiromi Matsubara,Ken-ichi Hirata,Ichizo Tsujino,Rika Suda,Hiroaki Miyata,Shiori Nishimura,Byron Sigel,Masashi Takano,Koichiro Tatsumi

JACC: Asia（2022）

引用 11|浏览6

暂无评分

摘要

The severity of PAH decreased over time in Japan. Oral/inhaled combination therapies were generally preferred. Physicians generally prescribed therapies after considering the patients' hemodynamics and clinical severity. (Japan Pulmonary Hypertension Registry [JAPHR]; UMIN000026680).

查看译文

关键词

Japan,pulmonary arterial hypertension,risk criteria,treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要